Tag: Dr. Sharvil Patel
Dr Sharvil Patel named IPA President; Glenn Saldanha takes over as...
Dr Sharvil Patel, Managing Director, Zydus Lifesciences appointed as President, IPA. Glenn Saldanha, Chairman and Managing Director, Glenmark, appointed as Vice President, IPA
Zydus Medtech and Braile Biomedica of Brazil announce global licensing pact...
The company gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Zydus Life Sciences to acquire a majority stake in Amplitude Surgical,...
Purchase consideration amounts to €256.8mn for 85.6% of the outstanding shares and voting rights of Amplitude Surgical
Zydus seeks DCGI’s EUA for world’s first Plasmid DNA based COVID-19...
The company has presented interim results from Phase III clinical trials in over 28,000 volunteers in a study carried out in more than 50 clinical sites spread across the country and during the peak of second wave of COVID-19.......................
Zydus launches Ujvira, a breakthrough biosimilar for breast cancer treatment
The world’s first biosimilar Antibody Drug Conjugate of Trastuzumab Emtansine will be priced at nearly 80% less than the currently available option in the market.......................
Zydus’s COVID-19 drug ‘Virafin’ gets DCGI nod
91.15% of patients treated with PegIFN were RT PCR negative by day 7. A single dose of the antiviral Virafin administered subcutaneously early on shows significant clinical and virological improvement in moderate COVID-19 adult patients.......................
Zydus seeks DCGI approval for the use of Pegylated Interferon alpha-2b...
Promising interim results from Phase III clinical trials with Pegylated Interferon alpha-2b in COVID-19 show higher clinical improvement.........................